A new approach to stroke prevention in Russia
- Authors: Feigin V.L.1,2,3, Varakin Y.Y.4, Kravchenko M.A.4, Piradov M.A.4, Tanashyan M.M.4, Gnedovskaya E.V.4, Stakhovskaya L.V.5,6, Shamalov N.A.5,6, Krishnamurthi R.1, Bhattacharjee R.1, Parmar P.1, Hussein T.1, Barker-Collo S.1
-
Affiliations:
- National Institute for Stroke and Applied Neurosciences at AUT University
- University of Washington
- Novosibirsk State Medical University
- Research Center of Neurology
- Research Institute of Cerebrovascular Pathology and Stroke
- Pirogov Russian National Research Medical University
- Issue: Vol 42, No 8 (2016)
- Pages: 854-857
- Section: Article
- URL: https://ogarev-online.ru/0362-1197/article/view/176989
- DOI: https://doi.org/10.1134/S0362119716080053
- ID: 176989
Cite item
Abstract
Considerable burden of stroke along with continuously increasing cost of medical help to stroke patients in Russia prompt to search for new and more efficient strategies for stroke prevention. These strategies should encompass improvement of people’s awareness of stroke symptoms and risk factors, as well as accessible information on how to modify the risk factors. Here we present the Stroke Riskometer™ app for smartphones which fulfills the abovementioned criteria. This tool has been developed based on research data and is acknowledged by the international medical community. Russian version is also available. The app allows to determine personal risk of stroke in adults within the next 5 to 10 years; it also helps to reveal personal risk factors for stroke and appropriate ways to mitigate these factors. We believe that wide use of this app in Russia will help to significantly reduce incidence of stroke.
Keywords
About the authors
V. L. Feigin
National Institute for Stroke and Applied Neurosciences at AUT University; University of Washington; Novosibirsk State Medical University
Email: in-epid@yandex.ru
New Zealand, Auckland; Seattle, WA; Novosibirsk
Yu. Ya. Varakin
Research Center of Neurology
Author for correspondence.
Email: in-epid@yandex.ru
Russian Federation, Moscow
M. A. Kravchenko
Research Center of Neurology
Email: in-epid@yandex.ru
Russian Federation, Moscow
M. A. Piradov
Research Center of Neurology
Email: in-epid@yandex.ru
Russian Federation, Moscow
M. M. Tanashyan
Research Center of Neurology
Email: in-epid@yandex.ru
Russian Federation, Moscow
E. V. Gnedovskaya
Research Center of Neurology
Email: in-epid@yandex.ru
Russian Federation, Moscow
L. V. Stakhovskaya
Research Institute of Cerebrovascular Pathology and Stroke; Pirogov Russian National Research Medical University
Email: in-epid@yandex.ru
Russian Federation, Moscow; Moscow
N. A. Shamalov
Research Institute of Cerebrovascular Pathology and Stroke; Pirogov Russian National Research Medical University
Email: in-epid@yandex.ru
Russian Federation, Moscow; Moscow
R. Krishnamurthi
National Institute for Stroke and Applied Neurosciences at AUT University
Email: in-epid@yandex.ru
New Zealand, Auckland
R. Bhattacharjee
National Institute for Stroke and Applied Neurosciences at AUT University
Email: in-epid@yandex.ru
New Zealand, Auckland
P. Parmar
National Institute for Stroke and Applied Neurosciences at AUT University
Email: in-epid@yandex.ru
New Zealand, Auckland
T. Hussein
National Institute for Stroke and Applied Neurosciences at AUT University
Email: in-epid@yandex.ru
New Zealand, Auckland
S. Barker-Collo
National Institute for Stroke and Applied Neurosciences at AUT University
Email: in-epid@yandex.ru
New Zealand, Auckland
Supplementary files
